可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Dilaveris PE, Gialafos EJ, Chrissos D, et al. Detection of hypertensive patients at risk for paroxysmal atrial fibrillation during sinus rhythm by computer-assisted P wave analysis[J]. J Hypertens, 1999, 17(10):1463-1470.[2] Nakashima H, Kumagai K, Urata H, et al. Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation[J]. Circulation, 2000, 101(22):2612-2617.[3] Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation.:aprospective and randomized study[J]. Circulation, 2002, 106(3):331-336.[4] Lopez B, Querejeta R, Varo N, et al. Usefulness of cardioreparative ability of antihypertensive treatment in hypertensive patients[J]. Circulation, 2001, 104(3):286-291.[5] Mitchell AR, Spurrell PA, Sulke N. Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation[J]. Am Heart J, 2003, 146(5):902-907.[6] Ciaroni S, Cuenoud L, Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension[J]. Am Heart J, 2000, 139(5):814-819.